Although RUNX1 and NPM1 mutations are mutually exclusive in AML29, RUNX1, a critical transcription factor in HSPCs and myelopoiesis, is frequently dysregulated in AML both genetically and transcriptionally. Here, RUNX1 is linked to acute myeloid leukemia.